Seattle, WA, United States of America

Steve Reed

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Emergent Travel Health Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steve Reed. Retrieved from https://idiyas.com/inventor/steve-reed-7u3m430n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Steve Reed - Innovator in Vaccine Development

Introduction

Steve Reed is a prominent inventor based in Seattle, WA. He has made significant contributions to the field of vaccine development, particularly in relation to Toxoplasma gondii. His innovative work has the potential to impact public health positively.

Latest Patents

Steve Reed holds a patent for Toxoplasma gondii vaccines and their use. This patent discloses polynucleotides encoding multi-epitope polypeptides and assemblies thereof, aimed at treating or limiting infection. He has 1 patent to his name, showcasing his expertise in this critical area of research.

Career Highlights

Reed is associated with Emergent Travel Health Inc., where he continues to work on advancing vaccine technologies. His role in the company allows him to collaborate with other experts in the field, further enhancing his contributions to vaccine development.

Collaborations

Steve Reed has worked alongside notable colleagues such as Rima McLeod and Kamal El Bissati. Their combined efforts in research and development have fostered innovation in the field of infectious disease prevention.

Conclusion

Steve Reed's work in vaccine development, particularly regarding Toxoplasma gondii, highlights his commitment to improving public health through innovative solutions. His contributions are invaluable in the ongoing fight against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…